YSN-95186-61715
2 vaccinations
5 coded responses
24 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 021 / MA
- Registered
- 2021-02-11
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-11
Registered in v-safe
-
2021-02-11
Dose 1 — Pfizer-BioNTech
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
-
2021-03-04
Dose 2 — Pfizer-BioNTech
-
2021-03-04
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: GoodFree text: Some dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Some soreness at the injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-06-03
Survey response — 3 months, dose 2MedDRA: Cough, Nasopharyngitis — Feeling: GoodFree text: Cold and coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-02
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis, Pregnancy — Feeling: FairFree text: Pregnant and coldMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-03-04
Survey response — 12 months, dose 2MedDRA: Delivery, Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, HospitalizationFree text: Symptoms: Pregnant and had the baby. · Healthcare visit (other): LaborMedDRA releases: 2024-11 · check-in free text available
-
2022-03-04
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Hospitalization · 1 call case(s)
- 2022-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-11 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-04 | Unsuccessful |
Free text
Release 5 — day 0, dose 2
Systemic reaction (other): Some dizziness
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Some soreness at the injection site
Release 8 — 3 months, dose 2
Symptoms: Cold and cough
Release 9 — 6 months, dose 2
Symptoms: Pregnant and cold
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Pregnancy | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release